Average Co-Inventor Count = 4.33
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (20 from 2,405 patents)
2. Schering Corporation (14 from 1,829 patents)
3. Angex Pharmaceutical, Inc. (3 from 3 patents)
4. Pharmacopeia Inc. (101 patents)
37 patents:
1. 11685761 - Cyclic di-nucleotide compounds as sting agonists
2. 11466047 - Cyclic di-nucleotide compounds as sting agonists
3. 11358949 - Carbamate and urea compounds as multikinase inhibitors
4. 11180497 - Cyclic compounds as immunomodulating agents
5. 11098046 - Macrocyclic compounds as TRK kinase inhibitors and uses thereof
6. 11008338 - C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use
7. 10689401 - C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use
8. 10414774 - Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease
9. 10414775 - Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease
10. 10071998 - Iminothiadiazine dioxides bearing an amine-linked substituent as BACE inhibitors, compositions, and their use
11. 9732088 - C2-carbocyclic iminothiazine dioxides as BACE inhibitors, compositions, and their use
12. 9725468 - C5-spiro iminothiazine dioxides as BACE inhibitors, compositions, and their use
13. 9499502 - 5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use
14. 9453034 - C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their use
15. 9365589 - C5, C6 oxacyclic-fused thiazine dioxide compounds as BACE inhibitors, compositions, and their use